NCT02950857View on ClinicalTrials.gov

A Study of EPEG in Beta Thalassemia Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

June 28, 2017

Primary Completion Date

September 27, 2017

Study Completion Date

September 27, 2017

Conditions
Beta-Thalassemia
Interventions
DRUG

EPEG

(Pegylated erythropoeitin)

Trial Locations (1)

50200

Faculty of Medicine, Chiang Mai University, Chiang Mai

Sponsors
All Listed Sponsors
lead

Prolong Pharmaceuticals

INDUSTRY